Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Diabetes Insipidus, Neurogenic"" wg kryterium: Temat


Tytuł:
Endocrine features of Langerhans cell histiocytosis in paediatric patients: A 30-year review.
Autorzy:
Alexander A; Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia.
Zacharin M; Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia.; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
Journal of paediatrics and child health [J Paediatr Child Health] 2024 Jan; Vol. 60 (1), pp. 24-27. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/etiology
Endocrine System Diseases*/diagnosis
Endocrine System Diseases*/epidemiology
Endocrine System Diseases*/etiology
Histiocytosis, Langerhans-Cell*/diagnosis
Histiocytosis, Langerhans-Cell*/epidemiology
Histiocytosis, Langerhans-Cell*/therapy
Child ; Humans ; Child, Preschool ; Retrospective Studies ; Victoria/epidemiology
Czasopismo naukowe
Tytuł:
Simplified drug efficacy evaluation system for vasopressin neurodegenerative disease using mouse disease-specific induced pluripotent stem cells.
Autorzy:
Miwata T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Suga H; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: .
Mitsumoto K; Department of Endocrinology and Diabetes, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
Zhang J; Division of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
Hamada Y; Division of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
Sakakibara M; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Soen M; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ozaki H; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Asano T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Miyata T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kawaguchi Y; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuda Y; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kobayashi T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Sugiyama M; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Onoue T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hagiwara D; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iwama S; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Oyadomari S; Division of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
Arima H; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
Peptides [Peptides] 2024 Mar; Vol. 173, pp. 171151. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Induced Pluripotent Stem Cells*/metabolism
Neurodegenerative Diseases*/drug therapy
Diabetes Insipidus, Neurogenic*/metabolism
Humans ; Mice ; Animals ; Arginine Vasopressin/metabolism ; Vasopressins/pharmacology ; Vasopressins/metabolism ; Neurophysins/genetics ; Mutant Proteins/metabolism ; Mutation
Czasopismo naukowe
Tytuł:
Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency.
Autorzy:
Kang H; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Park SS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Kim YH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Lim HS; Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.
Lee MK; Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.
Lee KR; Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.
Kim JH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Pituitary Center, Seoul National University Hospital, Seoul, Korea.
Kim YH; Pituitary Center, Seoul National University Hospital, Seoul, Korea.; Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 164-175. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/complications
Glycopeptides*
Hyponatremia*/diagnosis
Hyponatremia*/etiology
Pituitary Diseases*
Humans ; Arginine ; Sodium
Czasopismo naukowe
Tytuł:
Absence of anti-rabphilin-3A antibodies in children and young adults with idiopathic central diabetes insipidus: a potential clue to elucidating a tumor etiology.
Autorzy:
Fujisawa H; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Takeuchi T; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Ishii A; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Muto J; Department of Neurosurgery, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Kamasaki H; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Suzuki A; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Sugimura Y; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. .
Pokaż więcej
Źródło:
Hormones (Athens, Greece) [Hormones (Athens)] 2023 Dec; Vol. 22 (4), pp. 747-758. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Diabetes Insipidus*/diagnosis
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/etiology
Diabetes Insipidus, Neurogenic*/pathology
Diabetes Mellitus*
Germinoma*/complications
Germinoma*/pathology
Neoplasms*/pathology
Adolescent ; Child ; Humans ; Male ; Young Adult ; Magnetic Resonance Imaging/adverse effects ; Pituitary Gland/pathology
Czasopismo naukowe
Tytuł:
Glucocorticoid impact therapy for recurrent IgG4-related disease with diabetes insipidus as the main manifestation: A case report and literature review.
Autorzy:
Yu Y; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xu L
Wang Y
Li W
Wang Y
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Nov 17; Vol. 102 (46), pp. e36129.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/complications
Diabetes Insipidus, Neurogenic*/drug therapy
Immunoglobulin G4-Related Disease*/complications
Immunoglobulin G4-Related Disease*/drug therapy
Diabetes Insipidus*/complications
Diabetes Insipidus*/drug therapy
Diabetes Mellitus*/drug therapy
Male ; Humans ; Adult ; Glucocorticoids/therapeutic use ; Immunoglobulin G
Czasopismo naukowe
Tytuł:
Ibuprofen use for the treatment of pediatric patients with polyuria and dysnatremia. A case series report.
Autorzy:
Liern M; Department of Nephrology; Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Clement F; Department of Endocrinology. Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Niell C; Department of Endocrinology. Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Castro S; Department of Endocrinology. Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Sánchez Cestona S; Department of Nephrology; Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Lis D; Department of Nephrology; Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Bergadá I; Department of Endocrinology. Hospital General de Niños Ricardo Gutiérrez, City of Buenos Aires, Argentina.
Pokaż więcej
Transliterated Title:
Uso de ibuprofeno en el tratamiento de pacientes pediátricos con poliuria y disnatremia. Reporte de una serie de casos.
Źródło:
Archivos argentinos de pediatria [Arch Argent Pediatr] 2023 Dec 01; Vol. 121 (6), pp. e202310035. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
Hyponatremia*/drug therapy
Hyponatremia*/etiology
Diabetes Insipidus, Neurogenic*
Humans ; Child ; Polyuria/etiology ; Polyuria/complications ; Ibuprofen/therapeutic use ; Research
Czasopismo naukowe
Tytuł:
Assessment of quality of life in patients with craniopharyngioma and identification of risk factors for compromised overall wellness.
Autorzy:
Lin B; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.; These authors contributed equally to this work.
Xiang S; Department of Nursery, Huashan Hospital West Campus, Shanghai, China.; These authors contributed equally to this work.
Chen J; Department of Nursery, Huashan Hospital West Campus, Shanghai, China.; These authors contributed equally to this work.
Jing Y; Department of Endocrinology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; These authors contributed equally to this work.
Ye Z; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Zhang Y; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Cao X; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Yin Z; Department of Nursery, Huashan Hospital West Campus, Shanghai, China, .
Qiao N; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China, nidan_.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Zhou X; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China, .; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Pokaż więcej
Źródło:
Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2023 Nov 17; Vol. 68, pp. e230001.
Typ publikacji:
Journal Article
MeSH Terms:
Craniopharyngioma*/complications
Craniopharyngioma*/surgery
Diabetes Insipidus, Neurogenic*
Pituitary Neoplasms*/complications
Humans ; Quality of Life ; Risk Factors ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Copeptin analysis in endocrine disorders.
Autorzy:
Moodley N; Department of Chemical Pathology, Inkosi Albert Luthuli Central Hospital, National Health Laboratory Services, Durban, South Africa.; Department of Laboratory Medicine (Chemical Pathology), University of Kwa-Zulu Natal, Durban, South Africa.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 04; Vol. 14, pp. 1230045. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Insipidus, Neurogenic*
Child ; Adult ; Humans ; Glycopeptides ; Arginine Vasopressin ; Arginine
Czasopismo naukowe
Tytuł:
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Autorzy:
Korkmaz HA; Division of Pediatric Endocrinology, Department of Pediatrics, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir, Turkey. .
Arya VB; Division of Pediatric Endocrinology, Variety Club Children's Hospital, King's College Hospital NHS Foundation Trust, London, UK.; Faculty of Medicine and Life Science, King's College London, London, UK.
Gönüllü A; Department of Pediatrics, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir, Turkey.
Coşkunol F; Department of Pediatrics, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir, Turkey.
Ozkan B; Division of Pediatric Endocrinology, Department of Pediatrics, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir, Turkey.
Pokaż więcej
Źródło:
Paediatric drugs [Paediatr Drugs] 2023 Sep; Vol. 25 (5), pp. 595-601. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/drug therapy
Diabetes Insipidus, Neurogenic*/etiology
Disabled Children*
Hypernatremia*/drug therapy
Hyponatremia*/drug therapy
Hyponatremia*/etiology
Diabetes Mellitus*/drug therapy
Male ; Child ; Female ; Humans ; Child, Preschool ; Deamino Arginine Vasopressin/adverse effects ; Retrospective Studies ; Sodium/therapeutic use
Czasopismo naukowe
Tytuł:
Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
Autorzy:
Ohashi A; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan. atsuki_.
Takeda Y; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan.
Watada M; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan.
Ihara F; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan.
Oshita T; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan.
Iwata N; Department of Endocrinology and Metabolism, Fujita Health University, Toyoake, Japan.; Department of Endocrinology and Diabetes, Daido Hospital, Toyoake, Japan.
Fujisawa H; Department of Endocrinology and Metabolism, Fujita Health University, Toyoake, Japan.
Suzuki A; Department of Endocrinology and Metabolism, Fujita Health University, Toyoake, Japan.
Sugimura Y; Department of Endocrinology and Metabolism, Fujita Health University, Toyoake, Japan.
Maeda Y; Nephrology Division, Department of Internal Medicine, JA Toride Medical Center, 2-1-1 Hongo, Toride, Ibaraki, 302-0022, Japan.
Pokaż więcej
Źródło:
CEN case reports [CEN Case Rep] 2023 Aug; Vol. 12 (3), pp. 297-303. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/drug therapy
Diabetes Insipidus, Neurogenic*/etiology
Retroperitoneal Neoplasms*/complications
Diabetes Mellitus*
Female ; Humans ; Adult ; Deamino Arginine Vasopressin/therapeutic use
Czasopismo naukowe
Tytuł:
Neurogenic diabetes insipidus in a critical patient with COVID-19 pneumonia in treatment with extracorporeal membrane oxygenation: a case report.
Autorzy:
Samaniego-Segovia B; Internal Medicine Residents, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
Rizo-Topete L; Nephrology of the Critically Ill Patient, Internal Medicine, Internal Medicine Professor, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México - Associate Professor of Nephrology Service, Hospital Universitario 'José Eleuterio González', UANL, 64460 Monterrey, Nuevo León, México.
Garza-Gomez M; Internal Medicine Residents, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
Rodriguez-Salinas CA; Internal Medicine Residents, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
Martínez-Cadena S; Internal Medicine Residents, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
López-Romo A; Infectious Diseases, Internal Medicine, Internal Medicine Assistant Professor, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
Gomez-Gutierrez R; Pediatrics, Director of the ECMO Unit, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México.
Chavarría-Martínez U; Pulmonary and Critical Medicine, Internal Medicine Professor, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México - Pulmonary and Critical Medicine Professor, Hospital Universitario 'Dr. José Eleuterio González', UANL, 64460 Monterrey, Nuevo León, México.
Sánchez-Salazar S; Pulmonary and Critical Medicine, Internal Medicine Professor, Department of Health Sciences, Christus Muguerza Health System, UDEM, 64060 Monterrey, Nuevo León, México - Pulmonary and Critical Medicine Professor, Hospital Universitario 'Dr. José Eleuterio González', UANL, 64460 Monterrey, Nuevo León, México.
Pokaż więcej
Źródło:
The journal of extra-corporeal technology [J Extra Corpor Technol] 2023 Sep; Vol. 55 (3), pp. 134-137. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Case Reports
MeSH Terms:
Diabetes Insipidus, Neurogenic*
COVID-19*/complications
COVID-19*/therapy
Extracorporeal Membrane Oxygenation*
Respiratory Distress Syndrome*/etiology
Respiratory Distress Syndrome*/therapy
Diabetes Mellitus*
Female ; Humans ; Adult ; Polyuria ; Oxygen
Raport
Tytuł:
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
Autorzy:
Navarro-Gonzalez YD; Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Ventura-Juarez J; Departamento de Morfología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Muñoz-Ortega MH; Departamento de Química, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
González-Blas D; Departamento de Patología, Hospital General ISSSTE, Aguascalientes, Mexico.
Calvillo-Robedo A; Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Avila-Blanco ME; Departamento de Morfología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Valdez-Urias F; Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Quintanar-Stephano A; Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Pokaż więcej
Źródło:
International journal of experimental pathology [Int J Exp Pathol] 2023 Aug; Vol. 104 (4), pp. 209-222. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Vasopressin*/genetics
Diabetes Insipidus, Neurogenic*
Cricetinae ; Rats ; Animals ; Antidiuretic Hormone Receptor Antagonists/pharmacology ; Arginine Vasopressin/pharmacology ; Liver Cirrhosis/drug therapy ; Anastomosis, Surgical ; Arginine
Czasopismo naukowe
Tytuł:
A case of cerebral salt wasting syndrome in a patient with central diabetes insipidus and status epilepticus.
Autorzy:
Bernardi S; SS Endocrinologia, UCO Medicina Clinica, Ospedale di Cattinara, ASUGI, 34149, Trieste, Italy. .; Dipartimento di Scienze Mediche Chirurgiche e della Salute, Università degli Studi di Trieste, 34149, Trieste, Italy. .
Zorat F; SS Endocrinologia, UCO Medicina Clinica, Ospedale di Cattinara, ASUGI, 34149, Trieste, Italy.
Calabrò V; SS Endocrinologia, UCO Medicina Clinica, Ospedale di Cattinara, ASUGI, 34149, Trieste, Italy.
Faustini Fustini M; IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurochirurgia Ipofisi (Pituitary Unit), Ospedale Bellaria, 40139, Bologna, Italy.
Fabris B; SS Endocrinologia, UCO Medicina Clinica, Ospedale di Cattinara, ASUGI, 34149, Trieste, Italy.; Dipartimento di Scienze Mediche Chirurgiche e della Salute, Università degli Studi di Trieste, 34149, Trieste, Italy.
Pokaż więcej
Źródło:
Journal of endocrinological investigation [J Endocrinol Invest] 2023 Jun; Vol. 46 (6), pp. 1275-1277. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Diabetes Insipidus, Neurogenic*/complications
Diabetes Insipidus, Neurogenic*/diagnosis
Hyponatremia*/diagnosis
Hyponatremia*/etiology
Status Epilepticus*/diagnosis
Status Epilepticus*/etiology
Diabetes Insipidus*
Diabetes Mellitus*
Humans
Raport
Tytuł:
AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Autorzy:
Partenope C; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Pedranzini Q; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Petri A; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Rabbone I; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Prodam F; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.; Endocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Bellone S; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Apr 18; Vol. 14, pp. 1166953. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Typ publikacji:
Case Reports
MeSH Terms:
COVID-19*/complications
Diabetes Insipidus*/complications
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/etiology
Diabetes Mellitus*
Hypophysitis*
Hypopituitarism*/etiology
Adolescent ; Humans ; Male ; BNT162 Vaccine ; COVID-19 Vaccines/adverse effects ; Deamino Arginine Vasopressin ; Immunization/adverse effects ; Polydipsia/complications ; Polyuria/complications ; SARS-CoV-2
Raport
Tytuł:
Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus.
Autorzy:
Chen X; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhang S; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Peng X; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Shi X; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wu H; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wen Y; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Qin Y; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Tian X; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhu H; Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Chen L; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 May 12; Vol. 14, pp. 1173903. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023).
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Insipidus, Neurogenic*
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/complications
Diabetes Mellitus*
Male ; Humans ; Aged ; Middle Aged ; Antibodies, Antineutrophil Cytoplasmic ; Case-Control Studies ; Myeloblastin
Czasopismo naukowe
Tytuł:
Arginine-stimulated copeptin in children and adolescents.
Autorzy:
Binder G; Pediatric Endocrinology, University Children's Hospital Tübingen, Tübingen, Germany.
Weber K; Pediatric Endocrinology, University Children's Hospital Tübingen, Tübingen, Germany.
Peter A; Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Schweizer R; Pediatric Endocrinology, University Children's Hospital Tübingen, Tübingen, Germany.
Pokaż więcej
Źródło:
Clinical endocrinology [Clin Endocrinol (Oxf)] 2023 Apr; Vol. 98 (4), pp. 548-553. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arginine*
Diabetes Insipidus, Neurogenic*
Humans ; Child ; Adolescent ; Retrospective Studies ; Glycopeptides
Czasopismo naukowe
Tytuł:
A dog carrying mutations in AVP-NPII exhibits key features of central diabetes insipidus.
Autorzy:
Xu H; State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Hao H; Beijing Sinogene Biotechnology Co. Ltd, Beijing 100005, China.
Wang S; Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China.
Liu X; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Lyu W; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.
Zuo Z; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; Hefei Comprehensive National Science Center, Institute of Artificial Intelligence, Hefei, Anhui 230088, China.
Zhuo Y; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Mi J; Beijing Sinogene Biotechnology Co. Ltd, Beijing 100005, China.
Zhang YQ; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.
Tian R; State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: .
Zhu H; Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of genetics and genomics = Yi chuan xue bao [J Genet Genomics] 2023 Apr; Vol. 50 (4), pp. 280-283. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Insipidus, Neurogenic*/genetics
Diabetes Mellitus*/genetics
Dogs ; Animals ; Mutation ; Exons ; Pedigree
Raport
Tytuł:
Predictors of the Spontaneous Resolution of Central Diabetes Insipidus Following Endoscopic Endonasal Surgery for Craniopharyngioma.
Autorzy:
Pan C; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Qi J; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Wu J; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Wu B; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Xie S; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Wu X; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Tang B; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Hong T; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China. Electronic address: .
Pokaż więcej
Źródło:
World neurosurgery [World Neurosurg] 2023 Apr; Vol. 172, pp. e667-e678. Date of Electronic Publication: 2023 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Craniopharyngioma*/surgery
Craniopharyngioma*/complications
Diabetes Insipidus, Neurogenic*
Pituitary Neoplasms*/surgery
Pituitary Neoplasms*/complications
Hydrocephalus*/complications
Diabetes Insipidus*/epidemiology
Diabetes Insipidus*/etiology
Diabetes Mellitus*
Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common.
Autorzy:
Li JJ; Department of Internal Medicine, California University of Science and Medicine, Colton, CA, USA.
Tan S; Department of Internal Medicine, California University of Science and Medicine, Colton, CA, USA.
Kawashita T; Department of Internal Medicine, Arrowhead Regional Medical Center, Colton, CA, USA.
Tagle CA; Department of Internal Medicine, Arrowhead Regional Medical Center, Colton, CA, USA.
Farmand F; Department of Internal Medicine, Arrowhead Regional Medical Center, Colton, CA, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Jan 23; Vol. 24, pp. e939034. Date of Electronic Publication: 2023 Jan 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Diabetes Insipidus, Neurogenic*/chemically induced
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/drug therapy
Diabetes Insipidus, Nephrogenic*/chemically induced
Diabetes Insipidus, Nephrogenic*/diagnosis
Hypernatremia*/chemically induced
Diabetes Mellitus*
Female ; Humans ; Adult ; Lithium ; Polyuria/chemically induced ; Polyuria/complications
Czasopismo naukowe
Tytuł:
New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance).
Autorzy:
Angelousi A; First Department of Internal Medicine, Unit of Endocrinology, Laikon Hospital, Athens, Greece.
Alexandraki KI; Second Department of Surgery, Aretaieio Hospital Athens, Medical School, Athens, Greece.
Mytareli C; First Department of Internal Medicine, Unit of Endocrinology, Laikon Hospital, Athens, Greece.
Grossman AB; Green Templeton College, University of Oxford, Oxford, UK.; Centre for Endocrinology, Barts and the London School of Medicine, London, UK.; NET Unit, Royal Free Hospital, London, UK.
Kaltsas G; First Department of Propaedeutic Internal Medicine, Laikon Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło:
Journal of neuroendocrinology [J Neuroendocrinol] 2023 Jan; Vol. 35 (1), pp. e13233. Date of Electronic Publication: 2023 Jan 22.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Insipidus*/diagnosis
Diabetes Insipidus*/drug therapy
Diabetes Insipidus*/genetics
Diabetes Insipidus, Neurogenic*/diagnosis
Diabetes Insipidus, Neurogenic*/drug therapy
Diabetes Insipidus, Neurogenic*/genetics
Diabetes Insipidus, Nephrogenic*/diagnosis
Diabetes Insipidus, Nephrogenic*/genetics
Diabetes Insipidus, Nephrogenic*/therapy
Diabetes Mellitus*
Humans ; Aquaporin 2/genetics ; Receptors, Vasopressin/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies